Search for: "Lupin Limited" Results 1 - 20 of 80
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Nov 2021, 6:33 am by Robert Kraft
NPR reports that the FDA “said late last week that Lupin is voluntarily recalling certain dosages of irbesartan tablets and irbesartan and hydrochlorothiazide tablets” because certain batches of the blood pressure medications “were ‘above the specification limit for the impurity N-nitrosoirbesartan,’ which could cause cancer in humans. [read post]
14 Oct 2010, 10:50 pm by Varun Chhonkar
Warner Chilcott has announced to settle pending patent lawsuits against Lupin Limited over Warner's oral contraceptive drugs Loestrin 24 FE and Femcon FE. [read post]
13 Sep 2009, 9:31 pm
LLC • Defendants: Lupin Limited; Lupin Pharmaceuticals Inc. [read post]
20 Jan 2010, 12:34 pm by Varun R. Chhonkar
First case was filed on 6th day of the year 2010 by Teva Women’s Health (Duramed) against Pune-based generic manufacturer Lupin Limited (Teva Women’s Health, Inc. v. [read post]
3 May 2015, 9:59 pm by Patent Docs
Lupin Ltd. et al. 1:15-cv-03051; filed April 30, 2015 in the District Court of New Jersey • Plaintiffs: Horizon Pharma Ireland Ltd.; HZNP Limited; Horizon Pharma USA, Inc. [read post]
9 Jun 2008, 4:50 am
Lupin Limited et al. v. [read post]
12 Jul 2017, 2:15 am by Steve Brachmann
The decision allows Horizon Pharma to move forward with its argument that at least one of the two upheld patents would be infringed by generic versions of Vimovo being developed by Indian drugmakers Lupin Limited and Dr. [read post]
12 Sep 2012, 2:41 am by Bala Krishnan
  The plaintiffs have filed the suit after receiving notification under paragraph IV[1] from Lupin Limited stating that Lupin had filed an ANDA (Abbreviated NDA) application to seek approval to market a generic version of APRISO®. [read post]
1 Nov 2010, 11:41 am by The Docket Navigator
Lupin, Ltd. et al., 2-10-cv-00080 (NJD October 27, 2010, Order) (Hochberg, J.). [read post]
6 Nov 2007, 9:57 pm
Finally, Cobalt correctly notes that the impact of FDA's decision in this case will likely be limited, since there are only a handful of remaining cases governed by the pre-MMA version of the statute. [read post]
1 Jun 2011, 5:51 pm by FDABlog HPM
Karst –       Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]